BACKGROUND: This article provides a summary of the current status of the HIV/AIDS epidemic in Latin America, as well as an outline of the diverse responses to it. METHODS: A search of international databases (Pubmed and ISI-Web of Science), regional databases (Scielo and Lilacs), regional and national documents and UNAIDS reports. Data are presented according to subregion. RESULTS: In Mexico HIV remains concentrated among urban men who have sex with men (MSM), and has been growing among injecting drug users (IDU) and in rural areas in relation to migration. An increasing proportion of women among those affected is observed in all countries in Central America, the most affected region, as well as increasing the impact on other vulnerable groups, such as indigenous populations. The Andean Countries have urban epidemics concentrated among MSM. In Peru, non-traditional vulnerable populations were identified. In the Southern Cone heterosexual transmission became more relevant, probably in connection with IDU epidemics and is increasingly affecting lower income groups. Incidence rates have been declining since 2002 in Brazil, the first country to guarantee free, universal access to antiretrovirals, where one-third of drug-naïve patients are still initiating treatment at an advanced stage. Generally, access to treatment has improved as a result of support from the Global Fund and other initiatives, but there are concerns regarding coverage, equity and sustainability. CONCLUSIONS: HIV is still concentrated among MSM in Latin America. Non-traditional vulnerable groups such as migrants and lower income populations, usually considered part of the general population, deserve attention. Programmes confronting sexual exclusion are still needed. Access to treatment has improved over time, but inequalities persist.
BACKGROUND: This article provides a summary of the current status of the HIV/AIDS epidemic in Latin America, as well as an outline of the diverse responses to it. METHODS: A search of international databases (Pubmed and ISI-Web of Science), regional databases (Scielo and Lilacs), regional and national documents and UNAIDS reports. Data are presented according to subregion. RESULTS: In Mexico HIV remains concentrated among urban men who have sex with men (MSM), and has been growing among injecting drug users (IDU) and in rural areas in relation to migration. An increasing proportion of women among those affected is observed in all countries in Central America, the most affected region, as well as increasing the impact on other vulnerable groups, such as indigenous populations. The Andean Countries have urban epidemics concentrated among MSM. In Peru, non-traditional vulnerable populations were identified. In the Southern Cone heterosexual transmission became more relevant, probably in connection with IDU epidemics and is increasingly affecting lower income groups. Incidence rates have been declining since 2002 in Brazil, the first country to guarantee free, universal access to antiretrovirals, where one-third of drug-naïve patients are still initiating treatment at an advanced stage. Generally, access to treatment has improved as a result of support from the Global Fund and other initiatives, but there are concerns regarding coverage, equity and sustainability. CONCLUSIONS: HIV is still concentrated among MSM in Latin America. Non-traditional vulnerable groups such as migrants and lower income populations, usually considered part of the general population, deserve attention. Programmes confronting sexual exclusion are still needed. Access to treatment has improved over time, but inequalities persist.
Authors: Rachel Rinehart; Deep Rao; Rivet K Amico; Eduardo Ruiz; Peter Brandes; Cecilia Correa; Siavash Pasalar; Javier R Lama; Ann Duerr; Yamile Molina Journal: AIDS Behav Date: 2019-03
Authors: Jorge Sánchez; Victor G Sal Y Rosas; James P Hughes; Jared M Baeten; Jonathan Fuchs; Susan P Buchbinder; Beryl A Koblin; Martín Casapia; Abner Ortiz; Connie Celum Journal: AIDS Date: 2011-02-20 Impact factor: 4.177
Authors: Carla Valenzuela; Cesar Ugarte-Gil; Jorge Paz; Juan Echevarria; Eduardo Gotuzzo; Sten H Vermund; Aaron M Kipp Journal: AIDS Behav Date: 2015-02
Authors: Paula Fraiman Blatyta; Brian Custer; Thelma Terezinha Gonçalez; Rebecca Birch; Maria Esther Lopes; Maria Ines Lopes Ferreira; Anna Barbara Carneiro Proietti; Ester Cerdeira Sabino; Kimberly Page; Cesar de Almeida-Neto Journal: Transfusion Date: 2013-03-22 Impact factor: 3.157
Authors: Santiago Avila-Rios; Christopher E Ormsby; Jonathan M Carlson; Humberto Valenzuela-Ponce; Juan Blanco-Heredia; Daniela Garrido-Rodriguez; Claudia Garcia-Morales; David Heckerman; Zabrina L Brumme; Simon Mallal; Mina John; Enrique Espinosa; Gustavo Reyes-Teran Journal: Retrovirology Date: 2009-08-10 Impact factor: 4.602
Authors: Monica Malta; Monica M F Magnanini; Maeve B Mello; Ana Roberta P Pascom; Yohana Linhares; Francisco I Bastos Journal: BMC Public Health Date: 2010-06-07 Impact factor: 3.295
Authors: Zelma B Costa; Gustavo C Machado; Mariza M Avelino; Clidenor Gomes Filho; Jose V Macedo Filho; Ana L Minuzzi; Marilia D Turchi; Mariane M A Stefani; Wayner Vieira de Souza; Celina Mt Martelli Journal: BMC Infect Dis Date: 2009-07-27 Impact factor: 3.090